Disease activity score-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis: data from the GUEPARD trial and ESPOIR cohort

OBJECTIVES: To compare the efficacy of disease activity score in 28 joints (DAS28ESR)-driven therapy with anti-tumour necrosis factor (patients from the GUEPARD trial) and routine care in patients with recent-onset rheumatoid arthritis (patients of the ESPOIR cohort). RESULTS: After matching GUEPARD...

Descripción completa

Detalles Bibliográficos
Autores principales: Soubrier, M, Lukas, C, Sibilia, J, Fautrel, B, Roux, F, Gossec, L, Patternotte, S, Dougados, M
Formato: Texto
Lenguaje:English
Publicado: BMJ Group 2011
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048626/
https://www.ncbi.nlm.nih.gov/pubmed/21242235
http://dx.doi.org/10.1136/ard.2010.137695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048626/
https://www.ncbi.nlm.nih.gov/pubmed/21242235
http://dx.doi.org/10.1136/ard.2010.137695

Ejemplares similares